PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BG vs. CTVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BG and CTVA is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

BG vs. CTVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bunge Limited (BG) and Corteva, Inc. (CTVA). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-27.19%
15.25%
BG
CTVA

Key characteristics

Sharpe Ratio

BG:

-0.54

CTVA:

1.35

Sortino Ratio

BG:

-0.58

CTVA:

2.37

Omega Ratio

BG:

0.93

CTVA:

1.31

Calmar Ratio

BG:

-0.38

CTVA:

1.22

Martin Ratio

BG:

-0.91

CTVA:

7.30

Ulcer Index

BG:

14.70%

CTVA:

5.56%

Daily Std Dev

BG:

24.85%

CTVA:

30.16%

Max Drawdown

BG:

-77.34%

CTVA:

-34.76%

Current Drawdown

BG:

-32.62%

CTVA:

-5.22%

Fundamentals

Market Cap

BG:

$11.11B

CTVA:

$42.83B

EPS

BG:

$7.91

CTVA:

$0.96

PE Ratio

BG:

10.06

CTVA:

64.92

PEG Ratio

BG:

1.71

CTVA:

1.21

Total Revenue (TTM)

BG:

$39.57B

CTVA:

$12.93B

Gross Profit (TTM)

BG:

$2.46B

CTVA:

$5.60B

EBITDA (TTM)

BG:

$1.56B

CTVA:

$2.59B

Returns By Period

In the year-to-date period, BG achieves a 2.29% return, which is significantly lower than CTVA's 9.41% return.


BG

YTD

2.29%

1M

0.56%

6M

-28.48%

1Y

-11.69%

5Y*

10.48%

10Y*

1.37%

CTVA

YTD

9.41%

1M

8.42%

6M

14.45%

1Y

38.26%

5Y*

18.81%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BG vs. CTVA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BG
The Risk-Adjusted Performance Rank of BG is 2020
Overall Rank
The Sharpe Ratio Rank of BG is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of BG is 1818
Sortino Ratio Rank
The Omega Ratio Rank of BG is 1818
Omega Ratio Rank
The Calmar Ratio Rank of BG is 2323
Calmar Ratio Rank
The Martin Ratio Rank of BG is 2525
Martin Ratio Rank

CTVA
The Risk-Adjusted Performance Rank of CTVA is 8585
Overall Rank
The Sharpe Ratio Rank of CTVA is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of CTVA is 8585
Sortino Ratio Rank
The Omega Ratio Rank of CTVA is 8484
Omega Ratio Rank
The Calmar Ratio Rank of CTVA is 8282
Calmar Ratio Rank
The Martin Ratio Rank of CTVA is 8787
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BG vs. CTVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bunge Limited (BG) and Corteva, Inc. (CTVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BG, currently valued at -0.54, compared to the broader market-2.000.002.004.00-0.541.35
The chart of Sortino ratio for BG, currently valued at -0.58, compared to the broader market-4.00-2.000.002.004.006.00-0.582.37
The chart of Omega ratio for BG, currently valued at 0.93, compared to the broader market0.501.001.502.000.931.31
The chart of Calmar ratio for BG, currently valued at -0.38, compared to the broader market0.002.004.006.00-0.381.22
The chart of Martin ratio for BG, currently valued at -0.91, compared to the broader market-10.000.0010.0020.0030.00-0.917.30
BG
CTVA

The current BG Sharpe Ratio is -0.54, which is lower than the CTVA Sharpe Ratio of 1.35. The chart below compares the historical Sharpe Ratios of BG and CTVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.54
1.35
BG
CTVA

Dividends

BG vs. CTVA - Dividend Comparison

BG's dividend yield for the trailing twelve months is around 3.40%, more than CTVA's 1.06% yield.


TTM20242023202220212020201920182017201620152014
BG
Bunge Limited
3.40%3.48%2.55%2.31%2.20%3.05%3.48%3.59%2.62%2.21%2.11%1.41%
CTVA
Corteva, Inc.
1.06%1.16%1.29%0.99%1.14%1.34%0.88%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BG vs. CTVA - Drawdown Comparison

The maximum BG drawdown since its inception was -77.34%, which is greater than CTVA's maximum drawdown of -34.76%. Use the drawdown chart below to compare losses from any high point for BG and CTVA. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-32.62%
-5.22%
BG
CTVA

Volatility

BG vs. CTVA - Volatility Comparison

The current volatility for Bunge Limited (BG) is 7.02%, while Corteva, Inc. (CTVA) has a volatility of 7.68%. This indicates that BG experiences smaller price fluctuations and is considered to be less risky than CTVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%6.00%7.00%8.00%9.00%10.00%11.00%AugustSeptemberOctoberNovemberDecember2025
7.02%
7.68%
BG
CTVA

Financials

BG vs. CTVA - Financials Comparison

This section allows you to compare key financial metrics between Bunge Limited and Corteva, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab